Not all beneficiaries can get the $50 GLP-1 doses
The Compounded GLP-1 Regulatory Window in June 2026: What Every Buyer Should Understand Before Enrolling If you're reading this in June 2026 and seriously considering any compounded GLP-1 program - including LIV Body's - there is genuine regulatory context you deserve to have before you make a decision
Each form differs in how it is administered and absorbed by the body, with injectables being more common for weight loss treatments
Patients approved for the PAP receive free Ozempic or Rybelsus from Novo Nordisk without registration charges or monthly fees
Following patent expiry in India, several pharmaceutical companies launched lower-cost semaglutide products, making GLP-1 therapy accessible to a much larger population
Industry Funding: From the study, the funder was Eli Lilly and Company, which provided the study drug and was involved in study design, data collection, data analyses, data interpretation, and writing of the report
